OVID: Ovid Rx Sotuvga nisbatan narx
Yuqori R&D xarajatlari va FDA nazorati raqobatchilar uchun kirishning sezilarli to'sig'ini yaratadi. Joriy P/S ko'paytirgichi ushbu afzalliklarning bozor qiymatini aks ettiradi, bunda 327.50 ko'rsatkichi ushbu darajani belgilaydi. Ovid Therapeutics Inc. (OVID) epilepsiyaning og'ir shakllari uchun terapiyalardan daromad keltiradi va patent himoyasi pediatrik MKS patologiyalarining butun umr davomida dori vositalariga bo'lgan ehtiyoji tufayli barqaror pul oqimini ta'minlaydi.
Ovid Therapeutics Inc. (OVID) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning xususiy kapitalga nisbati Ovid Therapeutics Inc.|OVID - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Ovid Rx|OVID - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Ovid Therapeutics Inc.|OVID - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Ovid Therapeutics|Oraliq qoplama koeffitsiyenti ovidrx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
OVID - Sof foyda|Kelajakdagi foyda Ovid Therapeutics Inc.|OVID - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Ovid Rx|OVID - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati OVID|OVID - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Ovid Therapeutics|OVID - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi ovidrx.com|OVID - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Ovid Therapeutics Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:OVID ovidrx.com
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan o'lchaydi va kapitalizatsiyaning fundamental normalardan chetga chiqishini aniqlaydi. Nevrologik patologiyalar uchun dori vositalari sintezini avtomatlashtiruvchi Ovid Therapeutics Inc. (OVID) uchun sotuvlar nisbatidagi narx tendentsiyasi kompaniya ishlanmalarining tijoratlashtirilishiga oid bozor kutganlarini aks ettiradi. 327.50 ning joriy qiymati aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash imkonini beradi. Ushbu koeffitsiyentni tahlil qilish investorga kompaniya uchun spekulyativ pufakni yoki chuqur qadrsizlanganlik bosqichini o'z vaqtida tan olishga yordam beradi.
Ovid Therapeutics Inc. kimlar bilan raqobatlashadi
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|vistagen.com - P/S multiplikatori|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
